Jordan Winter
0000-0002-5200-6557
University Hospitals
28 papers found
Refreshing results…
Towards a More Transformational Leadership Model in Academic Surgery
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment
A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems
Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinoma
Black race is independently associated with underutilization of preoperative chemotherapy in clinical stage T2 or higher gastric adenocarcinoma
Weight loss during neoadjuvant therapy for pancreatic cancer does not predict poor outcomes
Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis
Facility type and size-stratified analysis of management patterns and outcomes of patients with localized non-functional pancreatic neuroendocrine tumors
Medicare reimbursement for common general surgery procedures has declined over the last decade.
Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients
Clinical development of IDH1 inhibitors for cancer therapy
Weight Tracking as a Novel Prognostic Marker After Pancreatectomy
Intraoperative Cytologic Sampling for Resected Pancreatic and Periampullary Adenocarcinoma with Implications for Locoregional Recurrence-Free Survival
A Propensity-Matched Analysis of the Postoperative Venous Thromboembolism Rate After Pancreatoduodenectomy Based on Operative Approach
Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern Era
Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinoma
The importance of time‐to‐adjuvant treatment on survival with pancreatic cancer: A systematic review and meta‐analysis
Accuracy of cytopathology evaluation for resected benign and malignant pancreatic disease
Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database
Missing publications? Search for publications with a matching author name.